Source: https://www.addictionincorporated.com/learn-more/timeline/
Timestamp: 2019-04-26 02:47:13+00:00

Document:
President Obama signs the FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT in a Rose Garden ceremony.
The Senate votes overwhelmingly to impose federal regulation on cigarettes and other forms of tobacco, passing the landmark FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT.
The U.S. Court of Appeals for the District of Columbia Circuit largely upholds the honorable Gladys Kesslers landmark 2006 ruling, however, the appeals court rejected the governments bid to impose other remedies, including a request that the tobacco industry be forced to fund a national smoking-cessation program.
USA v. PHILIP MORRIS. Federal District Court Judge Gladys Kessler, ruling for the United States District Court for the District of Columbia, imposes strict new limitations on tobacco marketing.
Article Censorship by a tobacco company, by Herbert Barry III, is published online by Psychopharmacology.
DeNoble gives written testimony on behalf of plaintiffs in USA v. PHILIP MORRIS.
Trial begins for USA v. PHILIP MORRIS.
A five-judge appeals court unanimously reverses Figueroas 10-02-02 order to vacate the $1.25 billion arbitration award to Ellis Private Counsel a/k/a Castano Litigation Group and the full award is reinstated.
New York State Supreme Court Judge Judge Nicholas Figueroa throws out a $1.25 billion legal fee the largest issued out of the 1998 nationwide settlement of state litigation against the tobacco industry awarded to the lawyers who handled a private attorney general’s action in California, saying the amount is irrational.
Tobacco Lawsuit Fee: $1.25 Billion in Los Angeles Times, by Henry Weinstein.
Wendell Gauthier dies of liver cancer at his home in Metairie. He was 58.
The Department of Justice files a civil lawsuit against the major U.S. Tobacco companies.
During President Clintons State of the Union address, he announces that the DOJ shall file a civil lawsuit against the tobacco industry.
The MASTER SETTLEMENT AGREEMENT is announced between state Attorneys General and tobacco companies to settle lawsuits.
The McCain bill is effectively killed by a 53-to-46 roll-call vote in the senate.
Senator McCain announces the provisions in the manager’s amendment to the National Tobacco Policy and Youth Smoking Reductions Act.
Article Tobacco: A Philip Morris Overseas Lab Stirs Attention, by Suein L. Hwang and Milo Geyelin, in Wall Street Journal.
Article Documents Indicate Strategy of Targeting Teen Smokers, by John Schwartz, in The Washington Post.
PM chairman Geoffrey Bible and other tobacco CEOs testify before the House Commerce Committee regarding Clintons opposition to the proposed settlement to end lawsuits by all 50 states.
DeNoble appears with Gray Davis in Sacramento where he speaks to legislators, committee staff and members of the press.
Senator McCain, as Chairman of the Committee on Commerce, Science, and Transportation, introduces universal tobacco settlement act a/k/a McCain Bill.
U.S. Secretary of Health and Human Services Donna Shalala holds media availability at the White House following her meeting with tobacco industry whistleblowers, including DeNoble & Mele.
The Global Settlement Agreement is the first attempt at a settlement between the state attorneys general and the tobacco companies.
Tobacco companies offer a settlement that would include FDA regulation, money for anti-smoking campaigns, and bans on vending machines and outdoor advertising.
According to New York Times article “A Tangled Web of Factors Led to Tobacco Talks, by Barry Meier, the global settlement talks resume today in Chicago.
New York Times article “2 Top Cigarette Makers Seek Settlement, by John M. Broder, confirms that the tobacco industry has initiated negotiations.
Ellis/Castano amend their complaint to add then-Lieutenant Governor Gray Davis, thus becoming the Davis/Ellis case.
Article 1972 memo at Philip Morris promotes high of nicotine, by Gail Appleson, in Chicago Sun-Times.
Gary Light and Tom Doyle receive summons for civil case MARK DEAN v. GARY DEAN LIGHT AND JOHN DOE.
Article Justice Dept. Clears FDA Aide Accused of Lying to Hill Panel, by John Schwartz, in The Washington Post.
ELLIS, ET AL. v. R. J. REYNOLDS TOBACCO CO. is filed in California Superior Court in San Diego County.
Article All 7 Tobacco Executives in Perjury Probe Have Quite the Industry, by Myron Levin, published Los Angeles Times.
The CASTANO case is decertified by U.S. Court of Appeals for the Fifth Circuit.
Congressman Joe Barton writes letter to Janet Reno and David Kessler, accusing Mitch Zeller of perjury.
FDA releases written statement from William A. Farone, Ph.D. re: “The manipulation and control of nicotine and tar in the design and manufacture of cigarettes: a scientific perspective.
New York Times article Tobaccos Broken Ranks: The Overview; Industry Split By Major Deal In Tobacco Suit, by Barnaby J. Feder.
The Castano plaintiff lawyers settle with Liggett Group.
Republican governor Kirk Fordice directs attorneys for the office of Governor to file suit in the Mississippi Supreme Court to challenge Attorney General Michael C. Moores representation of Medicaid.
Article Fine-Tuning Marlboro, by Alix M. Freedman, appears in The Wall Street Journal.
DeNoble testifies before the Massachusetts State Senates Joint Committee on Health Care on behalf of its pending tobacco disclosure legislation.
Article Ex-Philip Morris Scientist To Be in Antismoking Ad appears in Wall Street Journal.
Financial world ranks Marlboro the world’s no. 2 most valuable brand behind Coca-Cola.
Article Documents Disclose Philip Morris Studied Nicotines Effect on Body, by Philip J. Hilts and Glenn Collins, in The New York Times.
Article Tobacco Lawsuit Phones Smoking: Class Action is the Biggest Ever, by Jeffrey Meitrodt, in Times-Picayune.
Article Judge OKs massive suit against tobacco companies, by David Talbot, in The Boston Herald.
Castano is conditionally certified as a class action the District Court.
DeNobles written response to Bliley request for additional answers concerning the issue of tobacco and health.
Article Cigarette Company Developed Tobacco With Stronger Nicotine, by Warren E. Leary, in The New York Times.
Thomas Bliley gives closing statement at Subcommittee on Health and the Environments Hearing on the Oversight of Tobacco Products, with FDA Commissioner David Kessler presenting additional evidence of nicotine manipulation.
Article Cigarette Safety Research Was Started Then Stopped, by Philip J. Hilts, in The New York Times.
Article Cigarette Makers Debated the Risks They Denied, by Philp J. Hilts, in The New York Times.
Thomas Bliley gives opening statement at Subcommittee on Health and the Environments Hearing on the Oversight of Tobacco Products, with president and CEO of the Council for Tobacco Research, appearing before the subcommittee.
Article Mississippi insists that tobacco giants pay for their sins , by Michael Janofsky, in The Houston Chronicle.
Attorney General Michael C. Moore files THE STATE OF MISSISSIPPI v. AMERICAN TOBACCO et. al., is filed in the Chancery Court of Jackson County, Mississippi (Case No. 94-1429).
Brown & Williamson is granted a Kentucky state court injunction, requiring Waxman and senator Ron Wyden to allow B&W to review company documents in their possession.
Article Lawyers for tobacco firm hid research, by Doug Levy, in USA Today.
Article Method to Produce Safer Cigarette Was Found in 60s, but Company Shelved Idea, by Philip J. Hilts, is published in The New York Times.
Article Tobacco Company Was Silent on Hazards, by Philip J. Hilts, is published in The New York Times.
Article Scientists Say Cigarette Company Suppressed Findings on Nicotine, by Philip J. Hilts, published in The New York Times.
DeNoble and Mele appear before the subcommittee.
DeNoble issues a written statement in advance of his 4-28-94 appearance before the subcommittee.
Article U.S. Agency Suggests Regulating Cigarettes as an Addictive Drug, by Philip J. Hilts, published in The New York Times.
Waxman writes to Victor inviting him to testify before the committee.
William Campbell writes letter to Henry Waxman, agreeing to waive Paul Meles confidentiality agreement so that he can testify before the subcommittee.
Article Bullies in Congress will hardly stop with cigarettes, by Philip Terzian, in Rocky Mountain News.
The seven top tobacco CEOs appear before the Subcommittee on Health and the Environment. Philip Morris President and CEO William I. Campbell agrees to release DeNoble from his confidentiality agreement so that he can testify.
Article 81 Tobacco Study Discussed Raising Levels of Nicotine, by Philip J. Hilts, in The New York Times.
Article Philip Morris Blocked 83 Paper Showing Tobacco Is Addictive, Panel Finds, by Philip J. Hilts, is published in The New York Times.
Waxman holds press conference, revealing Victor and his research, and inviting top tobacco CEOs to testify before the subcommittee.
PMUSA issues statement in response to Waxmans allegations.
Castano Litigation Group issues TEMPORARY RESTRAINING ORDER WITHOUT NOTICE AND ORDER TO SHOW CAUSE WHY PRELIMINARY INJUCTION SHOULD NOT ISSUE in the United States District Court for the Eastern District of Louisiana.
Wendell Gauthier files CASTANO et al v. AMERICAN TOBACCO.
Kessler appears before the Oversight Hearing on Tobacco Products Before the Subcommittee on Health and the Environment of the House Committee on Energy and Commerce.
Kessler writes follow-up letter to Bliley regarding his 03-18-94 request.
Philip Morris announces a $10 billion libel suit against ABC and against both the producer and reporter on the Day One story.
PMUSA president William Campbell writes follow-up letter to members of Congress announcing lawsuit.
Following phone conversation with Mitch Zeller, Herbert Barry writes detailed follow-up letter outlining various manuscripts submitted by Victor DeNoble for publication in PSYCHOPHARMACOLOGY.
DeNoble has follow-up meeting with Kessler and Tobacco Working Group.
Conference call with Mele and Mitch Zeller, David Kessler, Tom & Gary.
Thomas Bliley writesletter to Kessler, requesting all evidence in the FDAs possession regarding the intent of cigarette manufacturers with respect to the presence of nicotine in cigarettes.
Kessler writes letter to William Campbell and requests that FDA representatives be allowed to meet with members of your research, scientific, technical, and production staffs and to review relevant information.
Light & Doyle meet Paul (codenamed Cigarette Junior) at his laboratory.
Light & Doyle phone Paul Mele at the armed forces radio biology research institute in Bethesda, MD.He was willing to talk.
Gary Light & Tom Doyle meet with Victor at the Christiana Hilton in Newark, Delaware, then update the FDAs Tobacco Working Group.
A letter to the editor from Philip Morris President and CEO William I. Campbell is published in the New York Times.
DeNoble is discussed in status meeting with Kessler.
DeNoble first contacted by FDA Tobaco Working Group.
Letter from C.O.S.H. to Kessler.
FDAs Tobacco Working Group holds its second strategy meeting.
PMUSA president William I. Campbell sends letter to members of Congress and also shares with all PMUSA employees regarding DAY ONE broadcast.
ABC News airs DAY ONE episode titled Smoke Screen.
FDAs Tobacco Working Group holds its first strategy meeting.
FDA Commisioner David Kessler, responding to a petition asking FDA to regulate low-tar and low-nicotine cigarettes, writes letter to C.O.S.H. chairman Scott Ballin, stating that the Agency will consider the question of whether it has jurisdiction over nicotine-containing tobacco products.
Brown & Williamsons Research & Development department distributes a restricted competitive analysis of ammonia use in Marlboro cigarettes, PMS GLOBAL STRATEGY: MARLBORO PRODUCT TECHNOLOGY.
Health and Human Services Secretary Otis R. Brown, MD, distributes Surgeon Generals report, THE HEALTH CONSEQUENCES OF SMOKING: NICOTINE ADDICTION, to President George H.W. Bush and members of Congress.
DeNoble and Mele begin formal outplacement proceedings, i.e. although theyll continue to be paid, this is their last official day of work.
Osdene discusses DeNoble with Fred Newman who reiterates the importance of VD and Mele leaving PM feeling well regarding business decision.
Philip Morris submits its first answers to CIPOLLONE plaintiffs interrogatories. Answers are prepared by Thomas Osdene and Jim Charles.
According to Osdenes handwritten notes, on this day he and Jim Charles, Ted Sanders, and Max Hausermann discuss closing down Victors lab ASAP.
Marc Edells law firm, Porzio, Bromberg & Newman Esqs. serve request that defendant Philip Morris produce designated documents and things on 04-23-84.
Memo from DeNoble to Cathy Ellis re: neurochemical basis of acetaldehyde’s behavioral effects.
Marc Edells law firm, Porzio, Bromberg & Newman Esqs. serve notice that, starting on 03-20-84, the plaintiffs will take the deposition upon oral examination of Philip Morris Incorporated.
Bob Pages handwritten comments regarding Directors Meeting include a comment by Fred Newman: less writing the better.
DeNoble and Mele submit memorandum to Jim Charles entitled BEHAVIORAL EFFECTS OF TERMINATION OF CHRONICALLY ADMINISTERED NICOTINE-ACETALDEHYDE COMBINATIONS ON LEVER PRESSING MAINTAINED UNDER A FIXED RATIO SCHEDULE OF FOOD PRESENTATION IN RATS.
Victor submits memo to Jim Charles re: PROJECT 1610 BEHAVIORAL PHARMACOLOGY Objectives and Plans, 1984.
DeNoble writes to Dr. Herbert Barry to inform him that due to factors beyond my control, he must withdraw NICOTINE AS A POSITIVE REINFORCER IN RATS from consideration as a publication in PSYCHOPHARMACOLOGY.
DeNoble and Mele attend the American Psychological Associations 91st annual convention in Anaheim, CA.
Jim Charles handwritten note to Osdene re: NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE.
CIPOLLONE vs. LIGGETT GROUP filed in the U.S. District Court for the District of New Jersey in Newark.
Shook Hardy & Bacon lawyer Patrick Sirridge writes to Newman, transmitting an analysis of DeNobles published literature, unpublished manuscripts, and in-press manuscripts.
This document listing info regarding a Coca-Cola patent to convert ethanol into acetaldehyde. The written comments from VP of Development and Research, Bob Seligman, underscore the fact that PM is monitoring acetaldehyde-related patents and production, with an aim to manufacture it themselves, and very excited about its capacity to be called natural.
Denoble promoted to Associate Senior Scientist.
DeNoble submits memorandum to Jim Charles regarding Prostration and Discrimination Tests.
Project 1610. BEHAVIORAL PHARMACOLOGY ANNUAL REPORT 1983, written by DeNoble and Mele.
Memo from Jim Charles to Osdene, recommending Victor for promotion from Research Scientist to Associate Senior Scientist.
Memo from Osdene to McDowell re: Smoking and Health, A Look Into The Future.
Hausermann approves manuscript for NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE for publication in SCIENCE.
Memo from Holtzman to Hausermann re: hes approved NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE for publication, with proviso that Jim Charles will review text and improve where necessary.
DeNoble presentation RESEARCH OVERVIEW OF THE BEHAVIORAL PHARMACOLOGY LAB to Executive VP of Operations W.W. McDowell and senior management in NYC.
Victor and colleagues present informational content of NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE at MCV seminar “Behavioral Pharmacology of Nicotine”.
Memorandum from Hausermann to Lunsford in Manuscript Review Board re: Approval of Information for Presentation at a seminar at the Medical College of Virginia.
Memorandum from Hausermann to Holtzman: The attached abstract entitled NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE has been submitted to me for presentation at a seminar “Behavioral Pharmacology of Nicotine” sponsored by the Neuroscience Department, Medical College of Virginia, on November 8, 1982.
DeNobles manuscript for NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE is forwarded from Carol G. Lunsford to Senior VP Max Hausermann for his approval re publication in NATURE.
Biochemical Research Division Symposium for October 1982 is postponed until first quarter 1983.
In a memo to Jim Charles, DeNoble recommends promotion of Mele to the level of Research Scientist.
The abstract for BEHAVIORAL EFFECTS OF INTRAVENTRICULARLY ADMINISTERED (-)- NICOTINE ON FIXED RATIO SCHEDULES OF FOOD PRESENTATION IN RATS is published in the spring-summer 82 edition of PSYCHOPHARMACOLOGY.
Memo from Jim Charles: You are invited to attend a symposium entitled The Influence of Nicotine on Research Directions in Biochemistry to be held at the Lecture Hall on Wednesday, October 13, 1982. Topics include Nicotine as an Intravenously Delivered Positive Reinforcer: A Behavioral and Pharmacological Analysis, presented by DeNoble.
Victor submits memorandum to Jim Charles re PROJECT NUMBER 1610: BEHAVIORAL PHARMACOLOGY Objectives and Plans 1982-83.
Memorandum from Jim Charles to Osdene re: Topics for Richmond Meeting. Recommended topics for Behavioral Pharmacology Overview include Nicotine and Self-Administration and Nicotine and Dependency, with DeNoble as the suggested speaker for each.
Bob Pages and Judy Johns handwritten notes from Biochemical Division Project Leaders Meeting.
A for your review and early comments memorandum from Eichorn to Farone and Hausermann, et al, regarding NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE.
DeNoble submits (revised?) abstract for manuscript NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZEto Manuscript Review Board for publication in NATURE.
Hausermann approves EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND ITS TERMINATION ON SCHEDULE-CONTROLLED BEHAVIOR IN RATS for publication in SCIENCE and presentation at upcoming annual meeting of Society of Neuroscience on 10-24-82.
Denoble and Mele submit BEHAVIORAL PHARMACOLOGY LABORATORY PROGRESS REPORT, covering 03-01-81 thru 03-01-82.
Abstract submitted to Manuscript Review Board for INFLUENCE OF BEHAVIORAL FACTORS IN THE DEVELOPMENT OF TOLERANCE TO (-)- NICOTINE re approval for publication in Journal of Pharmacology and Therapeutics during 1983 and presentation at American Psychological Associations annual meeting in August 1983.
DeNoble submits abstract for manuscript NICOTINE AS A POSITIVE REINFORCER IN RATS: EFFECTS OF INFUSION DOSE AND FIXED-RATIO SIZE (co-written with Mele and Frank Ryan) to Manuscript Review Board for publication in NATURE.
Memo from Eichorn to Hausermann re: EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND ITS TERMINATION ON SCHEDULE-CONTROLLED BEHAVIOR IN RATS has been reviewed by Manuscript Review Board and is recommended for publication in SCIENCE and presentation at Society of Neuroscience on 10-24-82.
Handwritten response from A.J. Kassman to Eichorns 02-23-82 for your review and early comment memo Sounds like were into the animal testing business. I think were getting on thin ice.
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND ITS TERMINATION ON SCHEDULE-CONTROLLED BEHAVIOR IN RATS is submitted to Manuscript Review Board for approval re publication in SCIENCE and presentation at upcoming annual meeting of the Society for Neuroscience on 08-24-82. NOTE: THE ONLY VERSION I CAN FIND IS DATED MARCH 82.
Memo from Eichorn to DeNoble, advising him that the abstract of his manuscript ABSENCE OF DELETERIOUS BEHAVIORAL EFFECTS FOLLOWING WITHDRAWAL FROM CHRONIC NICOTINE ADMINISTRATION IN RATS has been reviewed by Hausermann and Directors and they have no problem with subject matter.
Handwritten memo from DeNoble to Jim Charles re: multiple phase filter that will remove many gas phase components from smoke.
DeNoble gives presentation on his research to New York management, detailing results of nicotine self-administration and acetaldehyde self-administration, together they make a supraadditive.
Victor receives memo from Eichorn informing him that the manuscript BEHAVIORAL EFFECTS OF INTRAVENTRICULARLY ADMINISTERED (-)-NICOTINE ON FIXED RATIO SCHEDULES OF FOOD PRESENTATION IN RATS has been approved for publication in Journal of Pharmacology, Biochemistry and Behavior.
Handwritten notes by Pages from group meeting with staff involved with nicotine receptor program, including Abood, Mele, Dragan, Seligman, DeNoble, Dunn, Gullotta, and Seeman.
Paul Mele begins employment in Behavioral Research Lab as Research Scientist.
Eichorn memo to Hausermann and Directors re: manuscript approval for BEHAVIORAL EFFECTS OF INTRAVENTRICULARLY ADMINISTERED (-)- NICOTINE ON FIXED RATIO SCHEDULES OF FOOD PRESENTATION IN RATS.
Memo from Dunn to Osdene outlining the Behavioral Research Labs Plans and Objectives 1982, Dunn identifies DeNoble, Paul Mele showing up for the first time and Dragan as the three principals in the Behavioral Pharmacology group.
DeNoble and Carron present STUDIES ON THE EFFECTS OF INTRAVENTRICULAR INFUSIONS OF (-)- NICOTINE ON BEHAVIOR MAINTAINED UNDER FIXED-RATIO SCHEDULES, at the Society for Neurosciences annual meeting in Los Angeles, CA. The abstract is published in Society for Neuroscience Abstracts 7.
DeNobles Performance Appraisal Form, covering his work from 2-1-81 to 9-1-81, signed by Dunn and Osdene.
Paul C. Mele, Ph.D. accepts position as “Research Scientist” in the Behavioral Research department.
Memo from Seligman to Eichorn, approving abstract for STUDIES ON THE EFFECTS OF INTRAVENTRICULAR INFUSIONS OF (-)- NICOTINE ON BEHAVIOR MAINTAINED UNDER FIXED RATIO SCHEDULES (FR), for presentation at Society for Neuroscience, 1981 Annual Meeting.
DeNoble and Carron submit PROGRESS IN BEHAVIORAL PHARMACOLOGY LABORATORY, FOR PERIOD BEGINNING JUNE 80 THRU MARCH 81, to Dunn.
Handwritten note from C.H. ODonohue to Eichorn re: Do we want it known that we do animal studies?
In reply to note from Eichorn to Osdene and others, Walter Gannon (director of product development for Philip Morris Inc.) writes: Are we willing to publish results of studies performed in-house on intact animals? Richard Thomson replies: Since word of this work and similar stuff does appear to find its way outside the company anyway, publication may be preferable to suspicions. Need to get legal okay out of N.Y. B.J. Kosakowski to Eichorn: Longest abstract Ive seen. Im still doubtful on publishing rat projects.
Handwritten note from Paul Eichorn to Seligman concerning Manuscript for Presentation re: STUDIES ON THE EFFECTS OF INTRAVENTRICULAR INFUSIONS OF (-)- NICOTINE ON BEHAVIOR MAINTAINED UNDER FIXED RATIO SCHEDULES (FR).
DeNobles Performance Appraisal Form, covering his work from 5-1-80 to 5-1-81, signed by Dunn and Osdene.
Abstract for STUDIES ON THE EFFECTS OF INTRAVENTRICULAR INFUSIONS OF (-)- NICOTINE ON BEHAVIOR MAINTAINED UNDER FIXED RATIO SCHEDULES (FR), by DeNoble and Carron, submitted to the Manuscript Review Board.
Memorandum from Dunn to Osdene re BEHAVIORAL RESEARCH ACCOMPLISHMENTS 1980. Includes overview of the Behavioral Pharmacology Program, written by DeNoble.
In a memo from Dunn to Osdene outlining his Plans and Objectives 1981, Dunn includes DeNobles Behavioral Pharmacology Program and lists the following planned studies: Nicotine Self-Administration; Nicotine-Induced Prostration Syndrome; Discrimination Studies (to evaluate nicotine analogues).
Memorandum from Osdene to Seligman re Status of Nicotine Program.
Memorandum from Jeffrey I. Seeman to Osdene re recent efforts in nicotine analogue synthesis and chemistry.
DeNoble and Carron submit a Progress Report for the Behavioral Pharmacology Program to Osdene, detailing how theyd begun a series of studies to evaluate nicotine and nicotine analogues.
Memorandum from Dunn to Osdene re 1600: Smoker Psychology progress report for August 80, includes update re DeNobles project The Discriminative Stimulus Properties of l-nicotine and Nicotine Analogues.
DeNoble and Carron submit memorandum to Dunn entitled Research Progress Concerning Discrimination and Prostration Studies.
DeNoble, Osdene, Dunn & Frank Ryan write memo to Seligman explaining the technique and purpose of self-administration studies.
Dunns monthly report for 1600: Smoker Psychology for June 1980, mentions that DeNobles working on two project.
Memorandum from Dunn to Osdene re: Behavioral Research Lab, Four Major Studies.
Dunns monthly report for 1600: Smoker Psychology project for April 1980, includes the first written abstracts by DeNoble.
Carolyn Levy and Lisa Carron submit memo to DeNoble re Discrimination Studies.
DeNoble submits memo to Dunn re Nicotine Program Behavioral Research Laboratory.
DeNoble starts work at PM and becomes project leader of the Behavioral Pharmacology Laboratory, previously known as the Comparative Psychology Program.
Memo from Dunn to Seligman, addressing lawyers concerns about in-house research on the psychopharmacology of nicotine.
Memo from Carolyn Levy & Lisa Carron to Dunn, outlining their Prostration Syndrome research with rats.
Memo from Dunn to Osdene re Behavioral Research Accomplishments 1979.
Memo from Dunn to Osdene re Plans and Objectives 1980.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.